PARIS (Reuters) - Sanofi on Tuesday announced it had reached an agreement with Janssen, a part of Johnson & Johnson, to develop and commercialize a vaccine candidate for extra-intestinal pathogenic E.coli. Under the terms of the deal, both parties will co-fund current and future research and development costs.
10, Oct 2023 06:27 AM
Sanofi in agreement with Janssen to develop E. coli the vaccine candidate
PARIS (Reuters) - Sanofi on Tuesday announced it had reached an agreement with Janssen... ..
Multipostit B2
Gesendet 7 Monate vor
24 Ansichten
aktualisiert 7 Monate vor
Multipostit B2
Männlich , Lives in France
Quelle und mehr : www.challenges.fr
Deine Reaktion?
LOL
LOVED
PURE
AW
FUNNY
BAD!
EEW
OMG!
ANGRY